X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

ORAL ONCOLOGY

期刊標題檢索 ORAL ONCOL 最新評論: It's like meeting two angel reviewers, there are no big problems, they... (2024-08-26)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[ORAL ONCOLOGY]您好,您是該頁面的第 47582 位訪客。

期刊簡介
期刊名稱ORAL ONCOLOGY ORAL ONCOLOGY
LetPub Score
7.7
51 ratings
Rate

Reputation
8.7

Influence
6.5

Speed
9.6

期刊簡稱ORAL ONCOL
ISSN1368-8375
E-ISSN1879-0593
h-index101
CiteScore
CiteScoreSJRSNIPCiteScore Rank
8.701.2571.379
Subject fieldQuartilesRankPercentile
Category: Dentistry
Subcategory: Oral Surgery
Q11 / 74
Category: Dentistry
Subcategory: Oncology
Q171 / 404
Category: Dentistry
Subcategory: Cancer Research
Q266 / 230

自引率 (2023-2024)5.00%自引率趨勢
掲載範囲
Oral Oncology is an international interdisciplinary journal which publishes high quality original research, clinical trials and review articles, editorials, and commentaries relating to the etiopathogenesis, epidemiology, prevention, clinical features, diagnosis, treatment and management of patients with neoplasms in the head and neck.

Oral Oncology is of interest to head and neck surgeons, radiation and medical oncologists, maxillo-facial surgeons, oto-rhino-laryngologists, plastic surgeons, pathologists, scientists, oral medical specialists, special care dentists, dental care professionals, general dental practitioners, public health physicians, palliative care physicians, nurses, radiologists, radiographers, dieticians, occupational therapists, speech and language therapists, nutritionists, clinical and health psychologists and counselors, professionals in end of life care, as well as others interested in these fields.
官方網站http://www.journals.elsevier.com/oral-oncology/
在線稿件提交https://www.editorialmanager.com/OO
開放訪問No
出版商Elsevier Ltd
主題領域医学
出版國/地區ENGLAND
發行頻率月刊
創刊年1997
每年文章數158每年文章數趨勢
黃金OA百分比18.63%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
DENTISTRY, ORAL SURGERY & MEDICINESCIEQ113/157
ONCOLOGYSCIEQ295/322
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1368-8375%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 3 Month(s)
競爭力 *來自作者的數據: About 25%
在線文章發布時間來自Elsevier的數據: Average 5 Week(s)
參考鏈接
相關期刊 【ORAL ONCOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PERIODONTOLOGY 2000H-index: 107

    CiteScore: 34.10
    JOURNAL OF CLINICAL PERIODONTOLOGYH-index: 132

    CiteScore: 13.30
    JOURNAL OF DENTAL RESEARCHH-index: 158

    CiteScore: 15.30
    INTERNATIONAL ENDODONTIC JOURNALH-index: 107

    CiteScore: 10.20
    JOURNAL OF DENTISTRYH-index: 101

    CiteScore: 7.30
    JOURNAL OF PROSTHETIC DENTISTRYH-index: 109

    CiteScore: 7.00
    JOURNAL OF PERIODONTOLOGYH-index: 142

    CiteScore: 9.10
    Clinical Implant Dentistry and Related ResearchH-index: 74

    CiteScore: 6.00
    JOURNAL OF ENDODONTICSH-index: 131

    CiteScore: 8.80
    Journal of Dental SciencesH-index: 14

    CiteScore: 5.10
    學科內最受檢索的期刊 頁面查看次數
    JOURNAL OF DENTAL RESEARCH66038
    JOURNAL OF DENTISTRY60153
    ORAL DISEASES52769
    Clinical Oral Investigations44453
    ARCHIVES OF ORAL BIOLOGY39349
    JOURNAL OF CLINICAL PERIODONTOLOGY35649
    JOURNAL OF PERIODONTOLOGY34642
    AMERICAN JOURNAL OF DENTISTRY33965
    JOURNAL OF ENDODONTICS31471
    Clinical Implant Dentistry and Related Research29341
  •  

    ORAL ONCOLOGY ORAL ONCOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)
  [ORAL ONCOLOGY] 的評論撰寫評論
作者: chairdu


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2024-08-26 11:18:16 評論於
It's like meeting two angel reviewers, there are no big problems, they have a deep understanding of our research ideas, and their questions are relatively simple.
(0) 讚! | chairdu

作者: Accept


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-21 17:01:57 評論於
The choice of ordering mode has no impact. Are you two reviewers?
(0) 讚! | Accept

作者: Accept


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-21 17:01:24 評論於
After the submission, one reviewer directly DIPed, I don't know if it was a direct rejection.
(0) 讚! | Accept

作者: chairdu


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2024-08-19 22:51:54 評論於
Submitted on 29th June 2024, minor revisions in about a month, ready for resubmission on 13th August. Choosing gold open access costs $4510, with a subscription option available. Not sure if choosing this option will have any impact.
(0) 讚! | chairdu

作者: 北风赤奋若


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-05 08:21:49 評論於
This seems to be a sister publication, I wonder what the quality is like
(0) 讚! | 北风赤奋若

作者: 蠢小葱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-13 11:18:26 評論於
2024.02.13 Submitted to Journal
2024.02.13 Reject
(0) 讚! | 蠢小葱

作者: 平乐mio


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-31 21:45:15 評論於
Do you need three copies of this picture?
(0) 讚! | 平乐mio

作者: 平乐mio


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-31 10:18:32 評論於
Do you need three repeated results?

:Do you want three repeated results?

:Do you require three repeated results?
(0) 讚! | 平乐mio

作者: 应龙司卿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-17 08:01:13 評論於
Could you please share the citation format for endnotes? Thank you
(0) 讚! | 应龙司卿

作者: 混元新曦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-25 11:08:12 評論於
Not worth investing in, it's just a letter
(0) 讚! | 混元新曦

作者: 一只海桃呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-09 23:22:44 評論於
Review speed: 1.0 | Submission hit rate: 25.0
Experience sharing: Hey, newbie here! I want to ask if it's worth it to convert the submission into a letter. Any thoughts on how letters are received?
(0) 讚! | 一只海桃呀

作者: 金顶念蕾


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-07 22:01:35 評論於
10.4 Status Update: Still Under Review
(0) 讚! | 金顶念蕾

作者: Constance Adelaide


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-02 12:55:50 評論於
Looking forward to your updates. My situation is exactly the same as yours
(0) 讚! | Constance Adelaide

作者: 金顶念蕾


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-19 17:12:06 評論於
Just now 9.19 Under review
(0) 讚! | 金顶念蕾

作者: 北陆皓洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-18 17:25:00 評論於
Have you received any requests to submit oral oncology reports? It seems that this journal does not have an impact factor
(0) 讚! | 北陆皓洁

作者: 金顶念蕾


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-16 10:58:50 評論於
The previous submission of the radiation therapy green paper was rejected, but after external review of the green paper, some suggestions were given. The paper was revised according to the suggestions and resubmitted to oral oncology on September 12, 2023. As of September 13, the status is "with editor." On September 18, it is still "with editor," but a new deadline was given. Hopefully, good luck will come
(0) 讚! | 金顶念蕾

作者: May Mathilda


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-12 08:46:06 評論於
Before two reviewers, the first reviewer praised and accepted the manuscript with a few comments. The second reviewer raised four major questions, one of which was to supplement smoking history, PS score, and pathological type data; also to provide a table of non-chemotherapy regimens and kappa values; and finally, made about 30 other minor and major suggestions including grammar, content details, etc. All suggestions were addressed as requested. The manuscript was eventually accepted on August 11th. The first submission to a non-water journal ?
(0) 讚! | May Mathilda

作者: May Mathilda


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-30 21:31:49 評論於
7-26 received revised version with two reviewers. The first reviewer provided no suggestions, recommending acceptance directly. The second reviewer raised over 30 questions, all of which were addressed in the response. The manuscript was resubmitted on 7-30, hoping for acceptance (as the first article in the forthcoming non-water-related issue
(0) 讚! | May Mathilda

作者: May Mathilda


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-23 16:36:47 評論於
Research focus: Head and neck tumors; Tumor experience sharing: Previously submitted for publication, rejected, then submitted to this journal on July 6, contacted by editor on July 7, under review as of July 13, sent to 2+ reviewers, with two reviewers agreeing to review, first reviewer completed on July 17, second reviewer completed on July 25, currently in the "required reviews completed" status, hoping for a positive outcome
(0) 讚! | May Mathilda

作者: Avery Gunther


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-03 10:45:49 評論於
Is there any news now?
(0) 讚! | Avery Gunther

作者: 重阳水曼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-05 12:42:10 評論於
I don't know what's going on either
(0) 讚! | 重阳水曼

作者: 玄冰玉环


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-29 20:41:27 評論於
Review speed: 1.0 | Submission success rate: 50.0
Sharing experience: The acceptance rate of self-introduction on the OO official website is 22%, which is not as high as introduced here. Another issue is that I found that the ratio of articles to letters in each issue is at least 1:1.5, or even close to 1:2. If the 22% includes letters, then the acceptance rate of articles is less than 10%, and many submissions are articles while editors request letters. Mainland Chinese articles account for slightly more than 20%, estimating approximately 40-50 articles published in China each year, naturally including letters, seem not as difficult as imagined
(0) 讚! | 玄冰玉环

作者: 太山天震


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-18 18:33:25 評論於
Is there a response now?
(0) 讚! | 太山天震

作者: 仙灵安白


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-08 22:39:17 評論於
Review speed: 2.0 | Submission hit rate: 25.0
Emphasized research direction: Oral tumor
Experience sharing: It's been a month with the editor and still no response. I've followed up once, not sure how long it will take
(0) 讚! | 仙灵安白

作者: 冷桃小哥哥


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-22 19:09:18 評論於
Well, it's been 4 days with no changes. Does that mean the results aren't good? ?
(0) 讚! | 冷桃小哥哥

首頁    上一頁    1    2    3    4    下一頁    末頁  (頁
/4)

開始撰寫 [ORAL ONCOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*